dhara nilesh shah, pharm.d. - university of houston nilesh shah, pharm.d. page 1 of 9 dhara nilesh...

Dhara Nilesh Shah, Pharm.D. of 9

Dhara Nilesh Shah, Pharm.D. Work Address University of Houston-College of Pharmacy Texas Medical Center, Room #223 1441 Moursund Street, Houston, Texas 77030 Email: [email protected] Education Doctor of Pharmacy Summa Cum Laude August 2004 – May 2008 University of Houston-College of Pharmacy Houston, Texas Post-Graduate Didactic Training Clinical Research Curriculum August 2009 – University of Texas Medical School Houston, Texas 15th Annual Fellows Course in Hospital Epidemiology and Infection Control July 6th – 8th, 2011 Johns Hopkins University Baltimore, Maryland Professional Training Infectious Diseases Fellow July 2009 – December 2011 University of Houston-College of Pharmacy, Houston, Texas Mentors: Kevin Garey, Pharm.D., M.S. and Herbert L. DuPont, M.D. Pharmacy Practice Resident July 2008 – June 2009 Memorial Hermann-Texas Medical Center, Houston, Texas Program Director: Bradley Domonoske, Pharm.D., BCPS Work Experience Staff Pharmacist July 2009 – June 2011 St. Luke’s Episcopal Hospital, Houston, Texas Pharmacy Technician September 2003 – August 2005 HPB Pharmacy, Houston, Texas


Pharmacy Clerk August 2001 – December 2001 Eckerd Pharmacy, Houston, Texas Professional Licenses & Certificates Preceptor License, Texas State Board of Pharmacy May 2010 Teaching Certificate, University of Houston-College of Pharmacy September 2008 Licensed Pharmacist #46668, Texas State Board of Pharmacy August 2008 Advanced Cardiac Life Support July 2008 Pharmacy-Based Immunization Delivery August 2006 Honors and Awards ICAAC Infectious Diseases Fellows Grant 2010, 2011 American Society of Microbiology Best Resident/Fellow Poster Winner 2010 American College of Clinical Pharmacy Special Recognition Award: Excellence in Clinical Skills 2008 University of Houston-College of Pharmacy Golden Key International Honor Society 2007 University of Houston Rho Chi Pharmaceutical Honor Society 2006 University of Houston-College of Pharmacy Sandra Evans Webb Scholarship 2007 – 2008 TSHP R&E Foundation Sandra Webb Endowed Scholarship 2007 – 2008 University of Houston-College of Pharmacy George Webber Endowed Scholarship 2006 – 2007 University of Houston-College of Pharmacy Pharmacy General Scholarship 2006 – 2007 University of Houston-College of Pharmacy Professional Organizations Infectious Diseases Society of America 2011– American College of Clinical Pharmacy 2010–


The Society of Infectious Disease Pharmacists 2010– American Society for Microbiology 2009– Other Professional Pharmacy-Related Activities Student Professionalism Committee 2006 – 2007 Class of 2008 Representative, University of Houston-College of Pharmacy Interviews for Incoming Class Candidates 2005 – 2007 Group Discussion Evaluator, University of Houston-College of Pharmacy Student Affairs Advisory Council 2005 – 2007 College of Pharmacy Representative, Texas Medical Center Formulary Update Project 2006 Volunteer, Memorial Family Medicine Center Class of 2008 International Day 2004 – 2005 Coordinator, University of Houston-College of Pharmacy

Research Skills Clinical research: Trained and have experience with grantsmanship, IRB submission, study designs (randomized controlled trials, cohort / case-control studies, case series), patient recruitment and follow-up, data collection, database (MS Access), and analysis (STATA software) In vitro / microbiology: Trained in basic microbiology (bacterial growth, maintenance, and culture), in vitro susceptibility, and strain typing of aerobic and anaerobic organisms. Currently utilizing molecular biology (PCR and real-time PCR) and cell culture techniques. Publications Tran TT, Palmer HP, Weston J, Hirsch EB, Shah DN, Cottreau J, Tam VH, Garey KW. Evaluation of a daptomycin dose optimization protocol: A potential policy for antibiotic stewardship programs. Am J Health Syst Pharm. In press Le F, Arora V, Shah DN, Salazar M, Palmer HR, Garey KW. A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: Implications for antibiotic stewardship programs. Pharmacother. 2012;32(2):129-134. Shah DN, Yau R, Weston J, Lasco TM, Salazar M, Palmer HR, Garey KW. Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes. J Antimicrob Chemother. 2011; 66(9):2146-51.


Garey KW, Ghantoji SS, Shah DN, Habib M, Arora V, Jiang ZD, DuPont HL. A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection. J Antimicrob Chemother. 2011; 66(12):2850-5. Halton K, Arora V, Singh V, Ghantoji SS, Shah DN, Garey KW. Bacterial Colonization on writing pens touched by healthcare professionals and hospitalized patients with and without cleaning the pen with alcohol-based hand sanitizing agent. Clin Microbiol Infect. 2011; 17(6):868-9. Hirsch EB, Cottreau JM, Ikwuagwu JO, Lusardi K, Mohr JF, Rodriguez SM, Shah DN, Tran TT. Significant publications on infectious diseases pharmacotherapy in 2010. Am J Health Syst Pharm. 2011; 68(21):2075-85. Shah D, Dang MDQ, Hasbun R, Koo HL, Jiang ZD, DuPont HL, and Garey KW. Clostridium difficile infection - An update on emerging antibiotic treatment options and antibiotic resistance. Exp Rev Anti-infect Ther. 2010; 8(5):555-64. Garey KW, Salazar M, Shah D, Rodrigue R, DuPont HL. Rifamycin antibiotics for treatment of Clostridium difficile-associated diarrhea. Annals of Pharmacotherapy. 2008; 42(6):827-35. Hendley R, Laegeler A, Clowe J, Shah D, Shields R, Stewart B. Preliminary 2006 comparison of Medicare Part D prescription drug plans. TSHP Journal. 2006; 7(2):6-11. Abstracts Grimes CZ, Shah DN, Koo HL, DuPont HL. Validity of recommended criteria for attributable mortality associated with Clostridium difficile Infection. IDSA 49th Annual Meeting, Boston, MA. October 20-23, 2011. Garey KW, Shah DN, Habib M, Lasco T. Clinical assessment of nanotechnology and miniaturized magnetic resonance to detect candidemia in hospitalized patients. IDSA 49th Annual Meeting, Boston, MA. October 20-23, 2011. Shah DN, Koo HL, Lasco TM, Palmer HR, Garey KW. Assessment of attributable mortality rate of candidemia in candidemia pts with inpatient mortality. 51st ICAAC, Chicago, IL. Sept 17-20, 2011. Shah DN, Dima-ala A, Dolormente K, Arora V, Garey KW. Incidence of antibiotic-associated diarrhea in hospitalized patients given broad spectrum antibiotics. 51st ICAAC, Chicago, IL. Sept 17-20, 2011.


Shah DN, Yau R, Weston J, Lasco T, Salazar M, Palmer H, Garey KW. Pre-exposure to antifungals as a risk factor for fluconazole-non-susceptible Candida species in hospitalised patients with candidemia. 21st ECCMID/27th ICC meeting, Milan, Italy. May 7-10, 2011. Santimaleeworagun W, Christensen J, Singh V, Shah DN, Chang KT ,Tam VH, Garey KW Molecular epidemiology of Clostridium difficile and prevalence of the NAP-1strain among patients admitted to a general and a private hospital in Houston, Texas USA. 21st ECCMID/27th ICC meeting, Milan, Italy. May 7-10, 2011.

Garey KW, Ghantoji S, Shah D, Habib M, Arora V, Jiang ZD, DuPont H. A randomised, double-blind, placebo-controlled pilot study to assess the effect of rifaximin “chaser” to prevent recurrent diarrhoea in patients with Clostridium difficile infection. 21st ECCMID/27th ICC meeting, Milan, Italy. May 7-10, 2011. Xu R, Salazar M, Weston JS, Shah DN, Putney KS, Garey KW. Susceptibility of Candida species in patients with candidemia. SCCM’s 40th Critical Care Congress, San Diego, CA. January 16-18, 2011. De La Cabada J, Jiang Z-D, Ghantoji SS, Garey KW, Lasco TM, Larocco M, Shah D, DuPont HL. Fecal lactoferrin in Clostridium difficile infection as a predictor of single bouts vs. recurrent disease. IDSA 48th Annual Meeting, Vancouver, Canada. October 21-24, 2010 (ORAL). Shah DN, Yau RW, Weston J, Lasco T, Salazar M, Palmer H, Garey KW. Utility of fluconazole as de-escalation therapy in patients with fluconazole-susceptible candidemia. ACCP 2010 Annual Meeting, Austin, TX. October 17-20, 2010 (ORAL). Gordon SM, Shah DN, Tran TC, Lasco T, Garey KW. Variations in time to blood culture positivity stratified by Candida species and fluconazole susceptibility. ACCP 2010 Annual Meeting, Austin, TX. October 17-20, 2010. Tran TC, Palmer HR, Weston JS, Hirsch EB, Shah DN, Cottreau JM, Tam VH, Garey KW. Daptomycin dose-effect relationship against vancomycin-resistant enterococcal bacteremia. ACCP 2010 Annual Meeting, Austin, TX. October 17-20, 2010. Shah DN, Yau RW, Weston J, Xu R, Salazar M, Palmer H, Garey KW. Changes to empiric antifungal therapy based on susceptibility testing results. 50th ICAAC, Boston MA. Sept 12-15, 2010. Tran TC, Palmer HR, Weston JS, Hirsch EB, Shah DN, Cottreau JM, Tam VH, Garey KW. Evaluation of daptomycin PK/PD dose optimization protocol. 50th ICAAC, Boston MA. Sept 12-15, 2010 (ORAL).


Xu R, Weston JS, Salazar M, Shah DN, Garey KW. Susceptibility and recurrence of Candida species before and after a formulary change from caspofungin to micafungin in patients with candidemia. 44th ASHP Midyear Meeting, Las Vegas, NV. Dec 5-10. Ad Hoc Journal Reviewer Infection Control and Hospital Epidemiology 2011 Journal of Epidemiology and Global Health 2011 Expert Opinion on Emerging Drugs 2011 American Journal of Health-System Pharmacy 2010, 2011 BMC Infectious Diseases 2010 Critical Care 2010 Teaching Experience: University of Houston-College of Pharmacy Didactic Teaching, Doctorate of Pharmacy Systemic Fungal Infections and Antifungal Agents (1 hour) November 2011 Gastrointestinal Infections (1 hour) October 2011 Cases on Fungal Infections and Clostridium difficile Infection (2 hours) June 2011 Fungi and Antifungal Agents (2 hours) June 2011 Influenza and More (2 hours) June 2011 Antimicrobials-Associated Kidney and Liver Damage (2 hours) June 2011 Clostridium difficile Infection (1 hour) October 2010 Influenza (1 hour) October 2010 Tuberculosis Lecture and Cases (3 hours) July 2010 Clostridium difficile Infection: Update on 2010 Guidelines and Cases (2 hours) June 2010 Aminoglycosides Overview (2 hours) June 2010 Irritable Bowel Syndrome (1 hour) October 2008 Experiential teaching, Doctorate of Pharmacy May 2010– Infectious Diseases Clinical Rotation (4 students per year) In-collaboration with: Kevin W. Garey, Pharm.D., MS PGY1 and PGY2 Pharmacy Residency Rotations May 2010– Infectious Diseases Clinical Rotation (4 residents per year) In-collaboration with: Kevin W. Garey, Pharm.D., M.S. Didactic teaching, Bachelors of Science in Pharmaceutical Science March 2010 Clinical literature evaluation: How to tackle this important task? (1 hour) Selected Presentations Updates from the 51st ICAAC meeting September 2011 Clostridium difficile Research Meeting St. Luke’s Episcopal Hospital


Updates from the 50th ICAAC meeting September 2010 Clostridium difficile Research Meeting St. Luke’s Episcopal Hospital Growing Concerns Regarding Management of Candidemia May 2010 Pharmacy Seminar St. Luke's Episcopal Hospital Clostridium difficile Infection April 2010 Patient Case conference St. Luke's Episcopal Hospital Colistin December 2009 Patient Case Conference St. Luke’s Episcopal Hospital Updates from the 49th ICAAC meeting September 2009 Focus: Clostridium difficile Infection St. Luke’s Episcopal Hospital Impact of a Warfarin Ordering Protocol for Hospitalized Patients: June 2009 A Quality Improvement Evaluation Clinical Pharmacists Presentation Memorial Hermann-Texas Medical Center Medication Variance Report April 2009 Pharmacy and Therapeutics Committee Memorial Hermann-Texas Medical Center Therapeutic Monitoring: Focus on Drug Levels January 2009 Medical Staff Inservice Memorial Hermann-Texas Medical Center Continuous / Extended Infusion of β-Lactam Antibiotics in January 2009 Critically Ill Patients Clinical Pharmacists Presentation Memorial Hermann-Texas Medical Center The Importance of Timely Drug Therapy December 2008 Pharmacy Staff Inservice Memorial Hermann-Texas Medical Center Complications of Liver Disease November 2008 Medical Staff Inservice Memorial Hermann-Texas Medical Center


Staphylococcus aureus Endocarditis October 2008 Clinical Pharmacists Presentation Memorial Hermann-Texas Medical Center Variceal Bleeding March 2008 Clinical Pharmacists Presentation Ben Taub General Hospital Clostridium difficile Associated Diarrhea October 2007 Clinical Pharmacists Presentation St. Luke’s Episcopal Hospital Nesiritide in Acute Decompensated Heart Failure October 2007 Senior Seminar University of Houston-College of Pharmacy Infectious Diseases Fellowship Rotations Clinical / Translational Research and Academic Scholarship December 2009 – December 2011 Mentors: Kevin Garey, Pharm.D., M.S. and Herbert L. DuPont, M.D. HIV Clinic Longitudinal until October 2010 Mentor: Rustin Crutchley, Pharm.D., AAHIVE Antimicrobial Stewardship Oncall Pager Longitudinal until June 2010 Mentors: Hannah Palmer, Pharm.D., BCPS; Jaye Weston, M.S. General Microbiology Laboratory July 2010 Mentor: Kevin Garey, Pharm.D., M.S. Chief Resident April 2010 – June 2010 Antimicrobial Stewardship & ID Consult Service October 2009 – December 2009 Mentors: Hannah Palmer, Pharm.D., BCPS; Jaye Weston, M.S. Orientation & Basic Training July 2009 – September 2009 Pharmacy Practice Residency Rotations Transplant June 2009 Preceptor: Latosha Mitchell, Pharm.D., BCPS Transplant May 2009 Preceptor: Latosha Mitchell, Pharm.D., BCPS


Transplant April 2009 Preceptor: Latosha Mitchell, Pharm.D., BCPS Management March 2009 Preceptor: James Maddock, R.Ph., M.P.A. Shock Trauma Intensive Care February 2009 Preceptor: Bradley Domonoske, Pharm.D., BCPS Pediatrics January 2009 Preceptor: Karen Severson, Pharm.D. Internal Medicine November 2008 Preceptor: Jigna Patel, Pharm.D. General Surgery October 2008 Preceptor: Bradley Domonoske, Pharm.D., BCPS Infectious Diseases September 2008 Preceptor: Edgar Rios, Pharm.D., BCPS Cardiac Care Unit August 2008 Preceptor: Brian Gulbis, Pharm.D., BCPS Community Service Harris County Public Health H1N1 Immunization 2009 Alief Community Health Fair 2006, 2007 City Wide Club Annual Thanksgiving Feast 2003, 2007 Novemberfest – The Center 2005 Science Fair Judge 2005 Race for the Cure 2005

dhara nilesh shah, pharm.d. - university of houston nilesh shah, pharm.d. page 1 of 9 dhara nilesh...

Documents